IL70005A0 - Novel benzodioxole derivatives,processes for the manufacture thereof and corresponding pharmaceutical compositions - Google Patents
Novel benzodioxole derivatives,processes for the manufacture thereof and corresponding pharmaceutical compositionsInfo
- Publication number
- IL70005A0 IL70005A0 IL70005A IL7000583A IL70005A0 IL 70005 A0 IL70005 A0 IL 70005A0 IL 70005 A IL70005 A IL 70005A IL 7000583 A IL7000583 A IL 7000583A IL 70005 A0 IL70005 A0 IL 70005A0
- Authority
- IL
- Israel
- Prior art keywords
- radical
- compound
- general formula
- alk
- given above
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 2
- 150000005528 benzodioxoles Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 34
- 229910052739 hydrogen Inorganic materials 0.000 abstract 16
- 239000001257 hydrogen Substances 0.000 abstract 16
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 14
- 150000003839 salts Chemical class 0.000 abstract 13
- 125000000217 alkyl group Chemical group 0.000 abstract 10
- 229910052736 halogen Inorganic materials 0.000 abstract 9
- 125000003545 alkoxy group Chemical group 0.000 abstract 8
- 125000004432 carbon atom Chemical group C* 0.000 abstract 8
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 8
- 150000002367 halogens Chemical class 0.000 abstract 7
- 125000003118 aryl group Chemical group 0.000 abstract 6
- 125000005842 heteroatom Chemical group 0.000 abstract 6
- 125000003342 alkenyl group Chemical group 0.000 abstract 4
- 125000004414 alkyl thio group Chemical group 0.000 abstract 4
- -1 hexa-methyleneimino, 4-morpholinyl Chemical group 0.000 abstract 4
- 229910052757 nitrogen Inorganic materials 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 239000002253 acid Substances 0.000 abstract 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 2
- 125000005236 alkanoylamino group Chemical group 0.000 abstract 2
- 125000004450 alkenylene group Chemical group 0.000 abstract 2
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 abstract 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 2
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 abstract 2
- 125000002947 alkylene group Chemical group 0.000 abstract 2
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- 150000001450 anions Chemical class 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 125000001589 carboacyl group Chemical group 0.000 abstract 2
- 125000000490 cinnamyl group Chemical group C(C=CC1=CC=CC=C1)* 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 229910021645 metal ion Inorganic materials 0.000 abstract 2
- 125000002950 monocyclic group Chemical group 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 150000008064 anhydrides Chemical class 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 238000011065 in-situ storage Methods 0.000 abstract 1
- 150000002736 metal compounds Chemical class 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Light Receiving Elements (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Waveguide Switches, Polarizers, And Phase Shifters (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
1. Claims (for the Contracting States : BE, CH, LI, DE, FR, GB, IT, LU, NL, SE) Compounds of the general formula I see diagramm : EP0107622,P32,F1 in which R1 represents an alkyl, alkenyl or alkynyl radical that is unsubstituted or substituted by halogen having an atomic number of up to 35, lower alkoxy or by lower alkylthio and has, in total, that is to say including the substituents, a maximum of 12 carbon atoms, or represents a phenyl or naphthyl radical that is unsubstituted or substituted by lower alkyl, lower cycloalkyl, lower alkoxy, lower alkylthio, lower alkylsulphonyl, trifluoromethyl, hydroxy, lower alkanoyl, lower alkanoylamino, lower alkoxycarbonylamino and/or by lower alkylsulphonylamino, a monocyclic five-membered hetero ring of aromatic character having two nitrogen atoms or one nitrogen atom and/or one oxygen or sulphur atom in the ring or a six-membered hetero ring of aromatic character having one or two nitrogen atoms in the ring, or a bicyclic radical consisting of the said five- or six-membered hetero rings of aromatic character with a fused benzene ring, alk represents an alkylene, alkenylene or alkylidene radical having a maximum of 5 carbon atoms, n1 represents 0, 1 or 2 and n2 represents 0 or 1, R2 , R3 and R4 each represents, independently of the others, hydrogen, lower alkyl, lower alkoxy or halogen, and A represents the radical -O-R5 wherein R5 represents hydrogen or an alkyl radical having a maximum of 12 carbon atoms that is unsubstituted or is substituted by lower alkoxy or by halogen, 2- or 3-lower alkenyl, 2-lower alkynyl, phenyl-lower alkyl or cinnamyl, in which the phenyl radical may be substituted in the same manner as under R1 , or A represents the radical see diagramm : EP0107622,P33,F1 in which either R6 and R7 each represents, independently of the other, hydrogen or lower alkyl, or R6 and R7 are bonded to one another and, together with the adjacent nitrogen atom, represent optionally lower alkyl-substituted tetra- to hexa-methyleneimino, 4-morpholinyl or 1H-tetrazol-1-yl, salts of compounds of the general formula I in which A represents OR5 wherein R5 represents hydrogen, with bases, and acid addition salts of compounds of the general formula I in which the radical R1 has a basic character, radicals designated "lower" having a maximum of 7 carbon atoms. 1. Claims (for the Contracting State AT) A process for the manufacture of compounds of the formula I see diagramm : EP0107622,P36,F2 in which R1 represents an alkyl, alkenyl or alkynyl radical that is unsubstituted or substituted by halogen having an atomic number of up to 35, lower alkoxy or by lower alkylthio and has, in total, that is to say including the substituents, a maximum of 12 carbon atoms, or represents a phenyl or naphthyl radical that is unsubstituted or substituted by lower alkyl, lower cycloalkyl, lower alkoxy, lower alkylthio, lower alkylsulphonyl, trifluoromethyl, hydroxy, lower alkanoyl, lower alkanoylamino, lower alkoxycarbonylamino and/or by lower alkylsulphonylamino, a monocyclic five-membered hetero ring of aromatic character having two nitrogen atoms or one nitrogen atom and/or one oxygen or sulphur atom in the ring or a six-membered hetero ring of aromatic character having one or two nitrogen atoms in the ring, or a bicyclic radical consisting of the said five- or six-membered hetero rings of aromatic character with a fused benzene ring, alk represents an alkylene, alkenylene or alkylidene radical having a maximum of 5 carbon atoms, n1 represents 0, 1 or 2 and n2 represents 0 or 1, R2 , R3 and R4 each represents, independently of the others, hydrogen, lower alkyl, lower alkoxy or halogen, and A represents the radical -O-R5 wherein R5 represents hydrogen or an alkyl radical having a maximum of 12 carbon atoms that is unsubstituted or is substituted by lower alkoxy or by halogen, 2- or 3-lower alkenyl, 2-lower alkynyl, phenyl-lower alkyl or cinnamyl, in which the phenyl radical may be substituted in the same manner as under R1 , or A represents the radical see diagramm : EP0107622,P36,F3 in which either R6 and R7 each represents, independently of the other, hydrogen or lower alkyl, or R6 and R7 are bonded to one another and, together with the adjacent nitrogen atom, represent optionally lower alkyl-substituted tetra- to hexa-methyleneimino, 4-morpholinyl or 1H-tetrazol-1-yl, salts of compounds of the general formula I in which A represents OR5 wherein R5 represents hydrogen with bases, and acid addition salts of compounds of the general formula I in which the radical R1 has a basic character, radicals designated "lower" having a maximum of 7 carbon atoms, characterised in that a) a compound of the general formula II see diagramm : EP0107622,P37,F1 in which R1 , alk, n1 , n2 , R2 , R3 and R4 have the meanings given above, or a salt thereof, is reacted with a compound of the general formula III see diagramm : EP0107622,P37,F2 in which Hal represents halogen and A has the meaning given above, or with a salt of such a compound in which A represents OR5 wherein R5 represents hydrogen, or b) in a compound of the general formula IV see diagramm : EP0107622,P37,F3 in which A**b represents carboxy, lower alkoxycarbonyl or acetyl, and R1 , alk, n1 , n2 , R2 , R3 , R4 and A have the meanings given in claim 1, the radical A**b is replaced by hydrogen, or c) for the manufacture of a compound of the general formula I in which A has the meaning given above with the exception of a radical OR5 in which R5 represents hydrogen, and R1 , alk, n2 , R2 , R3 and R4 have the meanings given above and n1 represents 1 or 2, a compound of the general formula V see diagramm : EP0107622,P37,F4 is reacted with a compound of the general formula VI R1 -(alk)n2 -S(O)n1-c -OH or with an anhydride thereof, in which A1 has the meaning given above for A with the exception of a radical OR5 in which R5 represents hydrogen, n1-c represents 1 or 2 and R2 , R3 and R4 , and R1 , alk and n2 have the meanings given above, or d) for the manufacture of a compound in which n2 is 1 or R1 is an aliphatic radical according to the definition and R1 or n2 , as the case may be, alk, n2 , R2 , R3 , R4 and A have the meanings given above, a compound of the general formula VII R1 -(alk)n2-d -Z**d in which Z**d represents a reactively esterified hydroxy group, especially halogen having an atomic number of at least 17, R1 has the meaning given above and n2 represents 1 or, if R2 is an aliphatic radical, may alternatively be 0, or a compound of the general formula VIII see diagramm : EP0107622,P37,F5 in which Z**dd (cation) represents a monovalent anion or the normal equivalent of a polyvalent anion and R1 and n1 have the meanings given above, is reacted with a salt of a compound of the general formula IX see diagramm : EP0107622,P38,F1 in which n1 , R2 , R3 , R4 and A have the meanings given in claim 1, or e) a metal compound, optionally formed in situ, of the general formula Xa or Xb R1 -(alk)n2 -M1 see diagramm : EP0107622,P38,F2 in which M1 represents a monovalent metal ion and M2 represents a divalent metal ion and R, alk and n2 have the meanings given above, is reacted with a compound of the general XIa or XIb see diagramm : EP0107622,P38,F3 see diagramm : EP0107622,P38,F4 in which Hal represents halogen and n1 , R2 , R3 , R4 and A have the meanings given above, or f) for the manufacture of a compound of the general formula I in which A represents OR5 wherein R5 represents hydrogen, and R1 , alk, n1 , n2 , R2 , R3 and R4 have the meanings given above, or a salt of this compound : in a compound of the general formula XIII see diagramm : EP0107622,P38,F5 in which A**f represents a group that can be converted into the carboxy group and R1 , alk, n1 , n2 , R2 , R3 and R4 have the meanings given above, the group A**f is converted into the carboxy group in free or salt form, or g) for the manufacture of a compound of the general formula I in which A has the meaning given above with the exception of a radical OR5 in which R5 represents hydrogen, and R1 , alk, n1 , n2 , R2 and R3 have the meanings given above : in a compound of the general formula XIV see diagramm : EP0107622,P38,F6 in which A**g represents a radical that can be converted into a radical CO-A1 in which A1 has the meaning given above for A with the exception of a radical OR5 in which R5 represents hydrogen, and R1 , alk, n1 , n2 , R2 , R3 and R4 have the meanings given in claim 1, the radical A**g is converted into the radical -CO-A1 , and h) if desired, a compound of the general formula I in which n1 represents 0 or 1 is oxidised to form the corresponding compound in which n1 represents 1 or 2, or i) if desired, a compound of the general formula I in which n1 represents 2 or 1 is reduced to form the corresponding compound in which n1 represents 1 or 0, and/or, if desired, a resulting compound of the general formula I is converted in a different manner known per se into a different compound of the general formula I, and/or a compound of the general formula I obtained in the form of a racemate is separated into the optical antipodes, and/or a resulting compound of the general formula I in which A represents OR5 wherein R5 represents hydrogen is converted into a salt with a base, or such a compound is freed from a resulting salt, or a resulting compound of the general formula I of basic character is converted into an acid addition salt, or such a compound is freed from a resulting salt.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH616382 | 1982-10-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL70005A0 true IL70005A0 (en) | 1984-01-31 |
Family
ID=4305256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL70005A IL70005A0 (en) | 1982-10-22 | 1983-10-19 | Novel benzodioxole derivatives,processes for the manufacture thereof and corresponding pharmaceutical compositions |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0107622B1 (en) |
| JP (1) | JPS5995284A (en) |
| AT (1) | ATE30722T1 (en) |
| AU (1) | AU567894B2 (en) |
| CA (1) | CA1223874A (en) |
| DE (1) | DE3374408D1 (en) |
| DK (1) | DK485583A (en) |
| ES (5) | ES8601959A1 (en) |
| FI (1) | FI833819A7 (en) |
| GR (1) | GR78709B (en) |
| IE (1) | IE56092B1 (en) |
| IL (1) | IL70005A0 (en) |
| NO (1) | NO833857L (en) |
| NZ (1) | NZ206035A (en) |
| PT (1) | PT77539B (en) |
| ZA (1) | ZA837811B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0158596A3 (en) * | 1984-04-06 | 1986-08-13 | Ciba-Geigy Ag | Benzodioxole derivatives, process for their preparation and pharmaceutical compositions |
| US6169107B1 (en) | 1993-04-28 | 2001-01-02 | Sumitomo Pharmaceutical Co., Ltd. | Indoloylguanidine derivatives |
| BRPI0516435B1 (en) | 2004-10-29 | 2021-09-21 | Kalypsys , Inc | COMPOUND, AND PHARMACEUTICAL COMPOSITION |
| DK1940815T3 (en) * | 2005-10-25 | 2018-11-05 | Kalypsys Inc | SALTS OF MODULATORS OF PPAR AND PROCEDURES FOR TREATMENT OF SUBSTITUTE DISEASES |
| CN101007798B (en) * | 2006-01-24 | 2011-01-26 | 中国人民解放军军事医学科学院毒物药物研究所 | Benzodioxole derivatives and their preparation method and medicinal uses |
| CN101007804B (en) * | 2006-01-25 | 2011-05-11 | 中国人民解放军军事医学科学院毒物药物研究所 | 1,3-benzodioxole-2,2-dicarboxylic acid derivatives and their preparation method and medicinal uses |
| US20080176861A1 (en) | 2007-01-23 | 2008-07-24 | Kalypsys, Inc. | Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis |
| EP2624811B1 (en) * | 2010-10-04 | 2017-06-21 | Firmenich SA | Benzodioxole derivatives as watery odorants |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3872105A (en) * | 1973-06-11 | 1975-03-18 | Merrell Inc Richard | Derivatives of 1,3-benzodioxole-2-carboxylic acid |
| GR75464B (en) * | 1981-04-24 | 1984-07-20 | Ciba Geigy | |
| EP0107623A1 (en) * | 1982-10-22 | 1984-05-02 | Ciba-Geigy Ag | Benzodioxole derivatives, process for their preparation and pharmaceutical compositions containing them |
-
1983
- 1983-10-17 EP EP83810479A patent/EP0107622B1/en not_active Expired
- 1983-10-17 AT AT83810479T patent/ATE30722T1/en not_active IP Right Cessation
- 1983-10-17 DE DE8383810479T patent/DE3374408D1/en not_active Expired
- 1983-10-19 FI FI833819A patent/FI833819A7/en not_active Application Discontinuation
- 1983-10-19 IL IL70005A patent/IL70005A0/en unknown
- 1983-10-20 CA CA000439384A patent/CA1223874A/en not_active Expired
- 1983-10-20 ZA ZA837811A patent/ZA837811B/en unknown
- 1983-10-20 ES ES526609A patent/ES8601959A1/en not_active Expired
- 1983-10-20 PT PT77539A patent/PT77539B/en unknown
- 1983-10-20 GR GR72757A patent/GR78709B/el unknown
- 1983-10-21 JP JP58196274A patent/JPS5995284A/en active Pending
- 1983-10-21 DK DK485583A patent/DK485583A/en not_active Application Discontinuation
- 1983-10-21 NZ NZ206035A patent/NZ206035A/en unknown
- 1983-10-21 NO NO833857A patent/NO833857L/en unknown
- 1983-10-21 IE IE2472/83A patent/IE56092B1/en unknown
- 1983-10-21 AU AU20489/83A patent/AU567894B2/en not_active Ceased
-
1985
- 1985-05-30 ES ES543681A patent/ES8603860A1/en not_active Expired
- 1985-05-30 ES ES543683A patent/ES8703449A1/en not_active Expired
- 1985-05-30 ES ES543682A patent/ES8608506A1/en not_active Expired
- 1985-05-30 ES ES543684A patent/ES8703450A1/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CA1223874A (en) | 1987-07-07 |
| PT77539B (en) | 1986-05-28 |
| AU567894B2 (en) | 1987-12-10 |
| EP0107622A1 (en) | 1984-05-02 |
| AU2048983A (en) | 1984-05-03 |
| FI833819A0 (en) | 1983-10-19 |
| ES8703449A1 (en) | 1987-02-16 |
| NO833857L (en) | 1984-04-24 |
| PT77539A (en) | 1983-11-01 |
| DK485583D0 (en) | 1983-10-21 |
| JPS5995284A (en) | 1984-06-01 |
| ATE30722T1 (en) | 1987-11-15 |
| ES543684A0 (en) | 1987-02-16 |
| FI833819A7 (en) | 1984-04-23 |
| EP0107622B1 (en) | 1987-11-11 |
| GR78709B (en) | 1984-09-27 |
| IE832472L (en) | 1984-04-22 |
| ES543682A0 (en) | 1986-06-16 |
| ES8608506A1 (en) | 1986-06-16 |
| ES543681A0 (en) | 1986-01-01 |
| ZA837811B (en) | 1984-08-29 |
| DK485583A (en) | 1984-04-23 |
| ES8703450A1 (en) | 1987-02-16 |
| ES8603860A1 (en) | 1986-01-01 |
| ES526609A0 (en) | 1985-11-16 |
| ES8601959A1 (en) | 1985-11-16 |
| IE56092B1 (en) | 1991-04-10 |
| DE3374408D1 (en) | 1987-12-17 |
| NZ206035A (en) | 1987-03-06 |
| ES543683A0 (en) | 1987-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI931190A0 (en) | TRIAZOLOPYRIDAZINFOERENINGAR, DERAS FRAMSTAELLNING OCH ANVAENDNING | |
| DE3374408D1 (en) | Benzodioxole derivatives, process for their preparation and pharmaceutical compositions containing them | |
| ES8604543A1 (en) | Piperazine derivatives with anticholinergic and/or antihistaminic activity | |
| US2701253A (en) | Substituted dithiolanes | |
| DE3572816D1 (en) | PYRIDAZINONE INOTROPIC AGENTS | |
| GB1384479A (en) | Phosphorus-containing amidines | |
| ES543556A0 (en) | PROCEDURE FOR OBTAINING COMPOUNDS OF 6-HYDROXY- LOWER ALKYL-PENEM | |
| ES540332A0 (en) | PROCEDURE TO PREPARE NEW PIRIMIDO (2,1-B) BENZO- TIAZOLES | |
| GB2107315B (en) | Alpha epsilon alkane diisocyanates and their use in polyurethane production | |
| ES8300724A1 (en) | Benzazol derivatives, processes for their preparation, their pharmaceutical composition and their application. | |
| ATE30415T1 (en) | ENKEPHALINAS INHIBITORS. | |
| GB1514514A (en) | Bispiperazido phosphorus and trispiperazidophosphorus compounds | |
| DE69114352D1 (en) | Improved chemiluminescent reagents and procedures. | |
| ATE4951T1 (en) | ISATOGEN DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE AS FUNGICIDES. | |
| ATE6512T1 (en) | AZOLYLALKYL-2,3-DIHYDROBENZOFURANE, FUNGICIDES CONTAINING THEM AND PROCESS FOR THEIR PRODUCTION. | |
| MX154916A (en) | PROCEDURE FOR THE PREPARATION OF 1,1-DIOXIDES OF 3,4-DIHYDRO 2H-1,2-BENZOTIAZIN-3-CARBOXAMIDE | |
| RO85269B (en) | Process for preparing 1, 2, 4-oxadiazine derivatives | |
| ZA827040B (en) | Triazinyallactams,a process for their preparation,their use as stabilizers for synthetic organic polymers and the polymers stabilized with them | |
| GB1285800A (en) | Diphenyl derivatives containing two heterocyclic ring systems, their manufacture and use |